COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry

Authors

Meryl Waldman, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Ninet Sinaii, Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland.
Arjun Sekar, Rochester Regional HealthFollow

Department

Nephrology

Document Type

Article

Publication Title

Kidney360

First Page

349

Last Page

362

DOI

10.34067/KID.0006832022

Volume

4

Issue

3

Publication Date

3-1-2023

Comments

See full list of authors at journal website.

PubMed ID

36996301

Recommended Citation

Waldman, M., Sinaii, N., & Sekar, A. (2023). COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry. Kidney360, 4 (3), 349-362. https://doi.org/10.34067/KID.0006832022